AUPH
Price
$8.34
Change
+$0.04 (+0.48%)
Updated
May 21 closing price
Capitalization
1.12B
70 days until earnings call
JSPR
Price
$4.82
Change
-$0.22 (-4.37%)
Updated
May 21 closing price
Capitalization
72.41M
Interact to see
Advertisement

AUPH vs JSPR

Header iconAUPH vs JSPR Comparison
Open Charts AUPH vs JSPRBanner chart's image
Aurinia Pharmaceuticals
Price$8.34
Change+$0.04 (+0.48%)
Volume$1.12M
Capitalization1.12B
Jasper Therapeutics
Price$4.82
Change-$0.22 (-4.37%)
Volume$191.56K
Capitalization72.41M
AUPH vs JSPR Comparison Chart
Loading...
AUPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AUPH vs. JSPR commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AUPH is a StrongBuy and JSPR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (AUPH: $8.34 vs. JSPR: $4.82)
Brand notoriety: AUPH and JSPR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AUPH: 89% vs. JSPR: 108%
Market capitalization -- AUPH: $1.12B vs. JSPR: $72.41M
AUPH [@Biotechnology] is valued at $1.12B. JSPR’s [@Biotechnology] market capitalization is $72.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AUPH’s FA Score shows that 0 FA rating(s) are green whileJSPR’s FA Score has 2 green FA rating(s).

  • AUPH’s FA Score: 0 green, 5 red.
  • JSPR’s FA Score: 2 green, 3 red.
According to our system of comparison, JSPR is a better buy in the long-term than AUPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AUPH’s TA Score shows that 7 TA indicator(s) are bullish while JSPR’s TA Score has 6 bullish TA indicator(s).

  • AUPH’s TA Score: 7 bullish, 2 bearish.
  • JSPR’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, AUPH is a better buy in the short-term than JSPR.

Price Growth

AUPH (@Biotechnology) experienced а +6.24% price change this week, while JSPR (@Biotechnology) price change was -0.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.07%. For the same industry, the average monthly price growth was +10.40%, and the average quarterly price growth was -0.77%.

Reported Earning Dates

AUPH is expected to report earnings on Jul 31, 2025.

JSPR is expected to report earnings on Feb 28, 2025.

Industries' Descriptions

@Biotechnology (+6.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AUPH($1.12B) has a higher market cap than JSPR($72.4M). AUPH YTD gains are higher at: -7.127 vs. JSPR (-77.456). AUPH has higher annual earnings (EBITDA): 31.7M vs. JSPR (-74.87M). AUPH has more cash in the bank: 358M vs. JSPR (71.6M). JSPR has less debt than AUPH: JSPR (1.81M) vs AUPH (79.4M). AUPH has higher revenues than JSPR: AUPH (235M) vs JSPR (0).
AUPHJSPRAUPH / JSPR
Capitalization1.12B72.4M1,548%
EBITDA31.7M-74.87M-42%
Gain YTD-7.127-77.4569%
P/E Ratio30.89N/A-
Revenue235M0-
Total Cash358M71.6M500%
Total Debt79.4M1.81M4,379%
FUNDAMENTALS RATINGS
AUPH: Fundamental Ratings
AUPH
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AUPHJSPR
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
67%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
60%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
62%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
59%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
75%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
59%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 2 days ago
71%
Declines
ODDS (%)
Bearish Trend 15 days ago
83%
Bearish Trend 15 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
67%
Aroon
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
AUPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCICX15.80N/A
N/A
Goldman Sachs Intl Eq Insghts C
TFEQX12.06N/A
N/A
Templeton Instl Intl Eq Ser Primary
MERDX34.60N/A
N/A
Meridian Growth Legacy
FSBCX19.94-0.19
-0.94%
Federated Hermes Global Allocation C
DFSTX45.97-1.27
-2.69%
DFA US Small Cap I

AUPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, AUPH has been loosely correlated with JSPR. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if AUPH jumps, then JSPR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AUPH
1D Price
Change %
AUPH100%
+0.48%
JSPR - AUPH
44%
Loosely correlated
-4.37%
VCYT - AUPH
39%
Loosely correlated
-4.17%
CMRX - AUPH
38%
Loosely correlated
N/A
KRYS - AUPH
37%
Loosely correlated
-3.70%
CRDF - AUPH
37%
Loosely correlated
-5.54%
More

JSPR and

Correlation & Price change

A.I.dvisor indicates that over the last year, JSPR has been loosely correlated with AUPH. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if JSPR jumps, then AUPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JSPR
1D Price
Change %
JSPR100%
-4.37%
AUPH - JSPR
44%
Loosely correlated
+0.48%
ATNF - JSPR
38%
Loosely correlated
-8.70%
AVXL - JSPR
38%
Loosely correlated
+3.32%
ABCL - JSPR
36%
Loosely correlated
-4.78%
ABOS - JSPR
36%
Loosely correlated
-1.89%
More